Investors argue that pharma CEO compensation should be tied to global access to COVID-19 vaccine

On Thursday, a group of institutional investors representing $3.5 trillion in assets under management urged pharmaceutical companies to tie executive pay to the availability of COVID-19 vaccines around the world. On Thursday, a group of institutional investors representing $3.5 trillion in assets under management urged pharmaceutical companies to tie executive pay to the availability of COVID-19 vaccines around the world. While the majority of residents in wealthier countries are vaccinated, and many are now receiving booster injections, vaccination rates on the African continent average approximately 10%. READ MORE